Sypek, J P; Jacobson, S; Vorys, A et al. (1993) Comparison of gamma interferon, tumor necrosis factor, and direct cell contact in activation of antimycobacterial defense in murine macrophages. Infect Immun 61:3901-6
|
Birkland, T P; Sypek, J P; Wyler, D J (1992) Soluble TNF and membrane TNF expressed on CD4+ T lymphocytes differ in their ability to activate macrophage antileishmanial defense. J Leukoc Biol 51:296-9
|
Sypek, J P; Matzilevich, M M; Wyler, D J (1991) Th2 lymphocyte clone can activate macrophage antileishmanial defense by a lymphokine-independent mechanism in vitro and can augment parasite attrition in vivo. Cell Immunol 133:178-86
|
Sypek, J P; Wyler, D J (1991) Antileishmanial defense in macrophages triggered by tumor necrosis factor expressed on CD4+ T lymphocyte plasma membrane. J Exp Med 174:755-9
|
Sypek, J P; Wyler, D J (1990) T-cell hybridomas reveal two distinct mechanisms of antileishmanial defense. Infect Immun 58:1146-52
|
Sypek, J P; Wyler, D J (1988) Susceptibility of lymphokine-resistant Leishmania to cell contact-mediated macrophage activation. J Infect Dis 158:392-7
|
North, T W; Wyler, D J (1987) DNA synthesis in promastigotes of Leishmania major and L. donovani. Mol Biochem Parasitol 22:215-21
|
Wyler, D J; Beller, D I; Sypek, J P (1987) Macrophage activation for antileishmanial defense by an apparently novel mechanism. J Immunol 138:1246-9
|
Wyler, D J (1987) Fibronectin in parasitic diseases. Rev Infect Dis 9 Suppl 4:S391-9
|
Crawford, G D; Wyler, D J; Dinarello, C A (1985) Parasite-monocyte interactions in human leishmaniasis: production of interleukin-1 in vitro. J Infect Dis 152:315-22
|
Showing the most recent 10 out of 13 publications